Alantra advises Halloran Consulting Group on its sale to ProductLife Group

Oct 2024

Sell-side advisory

Boston – Alantra has acted as financial advisor to Halloran Consulting Group, a life science consulting firm that provides strategic regulatory, quality, clinical, and organizational support in the pharmaceutical, biotechnology, and medical device sectors in the United States, on the sale to ProductLife Group, a trusted global leader in regulatory, scientific, compliance, and digital transformation consulting services for the life sciences.

Founded in 1998 by Laurie Halloran, Halloran is known for offering comprehensive solutions to help clients navigate complex regulatory environments, optimize operations, and accelerate product development. The Halloran team empowers clients to achieve critical business milestones, ensure product quality and safety, and maintain competitive advantage in highly regulated environments.

Utilizing its 1,900+ experts spread over 50 countries, PLG brings innovation into client’s projects through digitalization and cloud solutions. Its end-to-end approach along the entire product life cycle ensures that safe and effective medicines reach patients.

With a shared vision of supporting patient access, this acquisition unites PLG and Halloran under a commitment to provide safe and effective healthcare solutions across the globe. The partnership strengthens PLG’s growing presence in the North American market while providing complementary solutions to Halloran’s portfolio and expanding their global footprint to support customers throughout their product development journey.

Rusty Ray, Managing Director at Alantra, said: “This transaction is a great example of what sets Alantra apart: our ability to combine sector specialization and international reach with relentless persistence in achieving our clients’ goals, ultimately delivering the best possible solution for each project. The sale of Halloran attracted overwhelming interest from our existing network in the life sciences services sector, and ProductLife Group proved to be the best fit. We’re excited to see this partnership boost growth and innovation for both companies.”

This transaction strengthens Alantra’s credentials in the life sciences and pharmaceutical sectors, following recent advisory roles in key transactions such as the sales of Windstar Medical to Merz Lifecare, Pharm-Rx to Actylis, medneo UK to CVC DIF, vH Essentials® to Wellspring Consumer Healthcare, and Labguru to Battery Ventures.